Rheumatoid arthritis - Pathogenetic role of neuroendocrine axes and the peripheral nervous system;Rheumatoide arthritis - Pathogenetische bedeutung der neuroendokrinen achsen und des peripheren nervensystems

Medizinische Klinik

Volumn 97, Issue 12, 2002, Pages 720-729

  Härle, Peter ^a   Cutolo, Maurizio ^b   Schölmerich, Jürgen ^a   Straub, Rainer H ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Androgens; Estrogens; Norepinephrine; Rheumatoid arthritis; Substance P; Synovium; Therapy

Indexed keywords

ANDROGEN; CAPSAICIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; ESTROGEN; HYDROCORTISONE; NEUROTRANSMITTER; NORADRENALIN; PRASTERONE; SUBSTANCE P;

ACUTE PHASE RESPONSE; ADRENERGIC SYSTEM; ADRENERGIC TRANSMISSION; ANDROGEN BLOOD LEVEL; CHRONIC INFLAMMATION; FEEDBACK SYSTEM; HUMAN; HYDROCORTISONE BLOOD LEVEL; INFLAMMATION; NEUROENDOCRINE SYSTEM; PATHOGENESIS; PERIPHERAL NERVOUS SYSTEM; REVIEW; RHEUMATOID ARTHRITIS; SENSORY NERVE; SYMPATHETIC NERVE; SYNOVIUM;

ANDROGENS; ARTHRITIS, RHEUMATOID; DEHYDROEPIANDROSTERONE; FEEDBACK; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; JOINTS; NEUROTRANSMITTER AGENTS; PERIPHERAL NERVOUS SYSTEM; PITUITARY-ADRENAL SYSTEM; SYMPATHETIC NERVOUS SYSTEM;

EID: 0037115304     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-002-1216-y     Document Type: Review

References (106)

1. Ahmed M, Bjurholm A, Schultzberg M, Theodorsson E, Kreicbergs A. Increased levels of substance P and calcitonin gene-related peptide in rat adjuvant arthritis. A combined immunohistochemical and radioimmunoassay analysis. Arthritis Rheum 1995;38:699-709.
2. Andus T, Klebl F, Rogler G, Schölmerich J, Straub RH. Successful treatment of refractory ulcerative colitis with dehydroepiandrosterone (DHEA)-an open controlled pilot trial. Gastroenterology 2000;188:A116.
3. Baerwald CG, Laufenberg M, Specht T, Wichert P von, Bunnester GR, Krause A. Impaired sympathetic influence on the immune response in patients with rheumatoid arthritis due to lymphocyte subset-specific modulation of beta 2-adrenergic receptors. Br J Rheumatol 1997;36:1262-9.
4. Battaglia DF, J.M. B, Krasa HB, Thrun LA, Viguie C, Karsch FJ. Endotoxin inhibits the reproductive neuroendocrine axis while stimulating adrenal steroids: A simultaneous view from hypophyseal portal and peripheral blood. Endocrinology 1997;138:4273-81.
5. Besedovsky HO, del Rey A. Immune-neuro-endocrine interactions: Facts and hypotheses. Endocr Rev 1996;17:64-102.
6. Besedovsky HO, del Rey A, Sorkin E, Dinarello CA. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986;233:652-4.
7. Blass S, Engel JM, Burmester GR. The immunologic homunculus in rheumatoid arthritis. Arthritis Rheum 1999;42:2499-506.
8. Canon DA. Rheumatoid arthritis: Pathogenesis and future therapies. Annual Scientific Meeting of the American College of Rheumatology, Boston, Massachusetts, November 13-17, 1999.
9. Cash JM, Crofford LJ, Gallucci WT, Sternberg EM, Gold PW, Chrousos GP, Wilder RL. Pituitary-adrenal axis responsiveness to ovine corticotropin releasing hormone in patients with rheumatoid arthritis treated with low dose prednisone. J Rheumatol 1992;19:1692-6.
10. Castagnetta L, Cutolo M, Granata OM, Di Falco M, Bellavia V, Carruba G. Endocrine end-points in rheumatoid arthritis. Ann N Y Acad Sci 1999;876:180-91; discussion 191-2.
11. Castagnetta LA, Carruba G, Granata OM, Stefano R, Miele M, Schmitdt M, Cutolo M, Straub RH. Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthntis. J Rheumatol 2002: submitted.
12. Cerinic MM, Konttinen Y, Generini S, Cutolo M. Neuropeptides and steroid hormones in arthritis. Curr Opin Rheumatol 1998;10:220-35.
13. Chikanza IC, Petrou P, Kingsley G, Chrousos G, Panayi GS. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 1992;35:1281-8.
14. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332:1351-62.
15. Crisp AJ, Chapman CM, Kirkham SE, Schiller AL, Krane SM. Articular mastocytosis in rheumatoid arthritis. Arthritis Rheum 1984;27:845-51.
16. Cronstein BN. The mechanism of action of methotrexate. Rheum Dis Clin North Am 1997;23:739-55.
17. Cronstein BN, Montesinos MC, Weissmann G. Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. Proc Natl Acad Sci U S A 1999;96:6377-81.
18. Cutolo M, Accardo S. Villaggio B, Barone A, Sulli A, Balleari E. Androgen metabolism and inhibition of interleukin-1 synthesis in primary cultured human synovial macrophages. Mediators Inflamm 1995;4:138.
19. Cutolo M, Accardo S, Villaggio B, Clerico P, Indiveri F, Carruba G, Fecarotta E, Castagnetta L. Evidence for the presence of androgen receptors in the synovial tissue of rheumatoid arthritis patients and healthy controls. Arthritis Rheum 1992;35:1007-15.
20. Cutolo M, Balleari E, Giusti M, Intra E, Accardo S. Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1-5.
21. Cutolo M, Ballean E, Giusti M, Monachesi M, Accardo S. Sex hormone status of male patients with rheumatoid arthritis: Evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation. Arthritis Rheum 1988:31:1314-7.
22. Cutolo M, Foppiani L, Prete C, Ballarino P, Sulli A, Villaggio B, Seriolo B, Giusti M, Accardo S. Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J Rheumatol 1999;26:282-8.
23. Cutolo M, Giusti M, Villaggio B, Barone A, Accardo S, Sulli A, Granata O, Carruba G, Castagnetta L. Testosterone metabolism and cyclosporin A treatment in rheumatoid arthritis. Br J Rheumatol 1997;36:433-9.
24. Cutolo M, Sulli A, Seriolo B, Accardo S, Masi AT. Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 1995;13:217-26.
25. Cutolo M, Sulli A, Villaggio B, Seriolo B, Accardo S. Relations between steroid hormones and cytokines in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 1998;57:573-7.
26. Cutolo M, Wilder RL. Different roles for androgens and estrogens in the susceptibility to autoimmune rheumatic diseases. Rheum Dis Clin North Am 2000;26:825-39.
27. Daynes KA, Araneo, BA, Ershler WB, Maloney C, Li GZ, Ryu SY. Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J Immunol 1993;150:5219-0.
28. DiBattista JA, Martel-Pelletier J, Cloutier JM, Pelletier JP. Modulation of glucocorticoid receptor expression in human articular chondrocytes by cAMP and prostaglandins. J Rheumatol Suppl 1991;27:102-5.
29. Ebringer A, Wilson C, Tiwana H. Is rheumatoid arthritis a form of reactive arthritis? J Rheumatol 2000;27:559-63.
30. Ehrhart-Bornstein M, Hinson JP, Bornstein SR, Scherbaum WA, Vinson GP. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev 1998;19:101-43.
31. Eijsbouts A, van den Hoogen F, Laan R, de Waal Malefijt M, Hermus A, Sweep C, de Rooij DJ, van de Putte L. Similar response to adrenocorticotrophic hormone, cortisol and prolactin to surgery in rheumatoid arthritis and osteoarthritis. Br J Rheumatol 1998;37:1138-9.
32. Firestein GS, Nguyen K, Aupperle KR, Yeo M, Boyle DL, Zvaifler NJ. Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol 1996;149:2143-51.
33. Gruol DJ, Campbell NF, Bourgeois S. Cyclic AMP-dependent protein kinase promotes glucocorticoid receptor function. J Biol Chem 1986;261:4909-14.
34. Gudbjornsson B, Skogseid B, Oberg K Wide L, Hallgren R. Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis. Effect of glucocorticoids. J Rheumatol 1996;23:596-602.
35. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 2002;46:328-46.
36. Gutierrez MA, Garcia ME, Rodriguez JA, Mardonez G, Jacobelli S, Rivero S. Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: A controlled study using insulin hypoglycemia stress test and prolactin stimulation. J Rheumatol 1999;26:277-81.
37. Hales DB. Interleukin-1 inhibits Leydig cell steroidogenesis primarily by decreasing 17 alpha-hydroxylase/C17-20 lyase cytochrome P450 expression. Endocrinology 1992;131:2165-72.
38. Harbuz MS, Jessop DS. Is there a defect in cortisol pro-duction in rheumatoid arthritis? Rheumatology (Oxf) 1999;38:298-302.
39. Härle P. Carr DJJ, Straub RH. Die ausschaltung des sympathischen nervensystem oder die infektion mit HSV-1 frühren zu einer dramatischen. Verschlimmerung der kollagen-induzierten arthritis in DBA-1 mäusen. 108. Kongress der Deutschen Gesellschaft für Innere Medizin, Wiesbaden, 6-10. April 2002, Med Klin 2002;97:62.
40. Herrmann M, Herrmann M, Schölmerich J. Straub RH. Influence of cytokines and growth factors on distinct steroidogenic enzymes in vitro: A short tabular data collection. Ann N Y Acad Sci 2002;966:166-86.
41. Hu SK, Mitcho YL, Rath NC. Effect of estradiol on interleukin 1 synthesis by macrophages. Int J Immunopharmacol 1988;10:247-52.
42. Imai S, Tokunaga Y. Konttinen YT, Maeda T, Hukuda S, Santavirta S. Ultrastructure of the synovial sensory peptidergic fibers is distinctively altered in different phases of adjuvant induced arthritis in rats: Ultramorphological characterization combined with morphometric and immunohistochemical study for substance P, calcitonin gene related peptide, and protein gene product 9.5. J Rheumatol1997;24:2177-87.
43. Janig W, Levine JD, Michaelis M. Interactions of sympathetic and primary afferent neurons following nerve injury and tissue trauma. Prog Brain Res 1996;113:161-84.
44. Janossy G, Panayi G, Duke O, Bofill M, Poulter LW, Goldstein G. Rheumatoid arthritis: A disease of Tlymphocyte/macrophage immunoregulation. Lancet 1981;2:839-42.
45. Johnson EO, Vlachoyiannopoulos PG, Skopouli FN, Tzioufas AG, Moutsopoulos HM. Hypofunction of the stress axis in Sjogren's syndrome. J Rheumatol 1998;25:1508-14.
46. Kanda N, Tamaki K. Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol 1999;103:282-8.
47. Kanda N, Tsuchida T, Tamaki K. Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:1703-11.
48. Kanda N, Tsuchida T, Tamaki K. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum 1999;42:328-37.
49. Kanik KS, Chrousos GP, Schumacher HR, Crane ML, Yarboro CH, Wilder RL. Adrenocorticotropin, glucocorticoid, and androgen secretion in patients with new onset synovitis/rheumatoid arthritis: Relations with indices of inflammation. J Clin Endocrinol Metab 2000;85:1461-6.
50. Keller ET, Chang C, Ershler WB. Inhibition of NFkappaB activity through maintenance of Ikappa-Balpha levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter. J Biol Chem 1996;271:26267-75.
51. Khalkhah-Ellis Z, Seftor EA, Nieva DR, Handa RJ, Price RH Jr, Kirchmann DA, Baragi VM. Sharma RV, Bhalla RC, Moore TL, Hendrix MJ. Estrogen and progesterone regulation of human fibroblast-like synoviocyte function in vitro: Implications in rheumatoid arthritis. J Rheumatol 2000;27:1622-31.
52. Koch AE, Polverini PJ, Leibovich SJ. Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. Arthritis Rheum 1986;29:471-9.
53. Konttinen YT, Kemppinen P, Segerberg M, Hukkanen M, Rees R. Santavirta S, Sorsa T, Pertovaara A, Polak JM. Peripheral and spinal neural mechanisms in arthritis, with particular reference to treatment of inflammation and pain. Arthritis Rheum 1994;37:965-82.
54. Laemont KD, Schaefer CJ, Juneau PL, Schrier DJ. Effects of the phosphodiesterase inhibitor rolipram on streptococcal cell wall-induced arthritis in rats. Int J Immunopharmacol 1999;21:711-25.
55. Lee A, Coderre TJ, Basbaum AI, Levine JD. Sympathetic neuron factors involved in bradykinin-induced plasma extravasation in the rat. Brain Res 1991;557:146-8.
56. Levine JD, Clark R, Devor M, Helms C, Moskowitz MA, Basbaum AI. Intraneuronal substance P contributes to the severity of experimental arthritis. Science 1984;226:547-9.
57. Li ZG, Danis VA, Brooks PM. Effect of gonadal steroids. Clin Exp Rheumatol 1993;11:157-62.
58. Lieb K, Fiebich BL, Berger M, Bauer J, Schulze-Osthoff K. The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. J Immunol 1997:159:4952-8.
59. Lotz M, Vaughan JH, Carson DA. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988;241:1218-21.
60. Lotze MT, Frana LW, Sharrow SO, Robb RJ, Rosenberg SA. In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2. J Immunol 1985;134:157-66.
61. Macdiarmid F, Wang D, Duncan LJ, Purohit A, Ghilchick MW, Reed MJ. Stimulation of aromatase activity in breast fibroblasts by tumor necrosis factor alpha. Mol Cell Endocrinol 1994;106:17-21.
62. Malfait AM, Malik AS, Marinova-Mutafchieva L, Butler DM, Maini RN, Feldmann M. The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: Mechanisms of action. J Immunol 1999;162:6278-83.
63. Malfait AM, Williams RO, Malik AS, Maini RN, Feldmann M. Chronic relapsing homologous collagen-induced arthritis in DBA/1 mice as a model for testing disease-modifying and remission-inducing therapies. Arthritis Rheum 2001;44:1215-24.
64. Masi AT, Bijlsma JW, Chikanza IC, Pitzalis C, Cutolo M. Neuroendocrine, immunologic, and microvascular systems interactions in rheumatoid arthritis: Physiopathogenetic and therapeutic perspectives. Semin Arthritis Rheum 1999;29:65-81.
65. Mastorakos G, Chrousos GP, Weber JS. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 1993;77:1690-4.
66. McMichael AJ, Sasazuki T, McDevitt HO, Payne RO. Increased frequency of HLA-Cw3 and HLA-Dw4 in rheumatoid arthritis. Arthritis Rheum 1977;20:1037-42.
67. Michie HR, Spriggs DR, Manogue KR, Sherman ML, Revhaug A, O'Dwyer ST, Arthur K, Dinarello CA, Cerami A, Wolff SM, et al. Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 1988;104:280-6.
68. Miller LE, Grifka J, Schölmerich J, Straub RH. Norepinephrine from synovial tyrosine hydroxylase positive cells is a strong indicator of synovial inflammation in rheumatoid arthritis. J Rheumatol 2002;29:427-35.
69. Miller LE, Jüsten HP, Schölmerich J, Straub RH. The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J 2000;14:2097-107.
70. Motulsky HJ, Insel PA. Adrenergic receptors in man: Direct identification, physiologic regulation, and clinical alterations. N Engl J Med 1982;307:18-29.
71. Müller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, Gay S. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996;149:1607-15.
72. Munck A, Guyre PM. Glucocorticoid physiology, pharmacology and stress. Adv Exp Med Biol 1986;196:81-96.
73. Naitoh Y, Fukata J, Tominaga T, Nakai Y, Tamai S, Mori K, Imura H. Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats. Biochem Biophys Res Commun 1988;155:1459-63.
74. Nakamura H, Motoyoshi S, Kadokawa T. Anti-inflammatory action of interleukin 1 through the pituitary-adrenal axis in rats. Eur J Pharmacol 1988;151:67-73.
75. Niijima A, Hori T, Aou S, Oomura Y. The effects of interleukin-1 beta on the activity of adrenal, splenic and renal sympathetic nerves in the rat. J Auton Nerv Syst 1991;36:183-92.
76. Oikarinen J, Hamalainen L, Oikarinen A. Modulation of glucocorticoid receptor activity by cyclic nucleotides and its implications on the regulation of human skin fibroblast growth and protein synthesis. Biochim Biophys Acta 1984;799:158-65.
77. Pereira da Silva JA, Carmo-Fonseca M. Peptide containing nerves in human synovium: Immunohistochemical evidence for decreased innervation in rheumatoid arthritis. J Rheumatol 1990;17:1592-9.
78. Petri M, Lahita R, McGuire TC, van Vollenhoven RF, Strand V, Kunz A. Results of the GL701 (DHEA) multicenter steroid-spanng SLE study. Arthritis Rheum 1997;40:S327. abstract.
79. Polan ML, Kuo A, Loukides J, Bottomly K. Cultured human luteal peripheral monocytes secrete increased levels of interleukin-1. J Clin Endocrinol Metab 1990;70:480-4.
80. Purohit A, Ghilchik MW, Duncan L, Wang DY, Singh A, Walker MM, Reed MJ. Aromatase activity and interleukin-6 production by normal and malignant breast tissues. J Clin Endocrinol Metab 1995;80:3052-8.
81. Rameshwar P, Gascon P, Ganea D. Stimulation of IL-2 production in murine lymphocytes by substance P and related tachykinins. J Immunol 1993;151:2484-96.
82. Roudier J, Petersen J, Rhodes GH, Luka J, Carson DA. Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110. Proc Natl Acad Sci U S A 1989;86:5104-8.
83. Sanden S, Tripmacher R, Weltrich R, Rohde W, Hiepe F, Burmester GR, Buttgereit F. Glucocorticoid dose dependent downregulation of glucocorticoid receptors in patients with rheumatic diseases. J Rheumatol 2000;27:1265-70.
84. Schaible HG, Grubb BD. Afferent and spinal mechanisms ofjoint pain. Pain 1993;55:5-54.
85. Schmidt M, Kreutz M, Löffler G, Schölmerich J, Straub RH. Conversion of dehydroepiandrosterone to downstream steroid hormones in macrophages. J Endocrinol 2000;164:161-9.
86. Schubert D, LaCorbiere M, Klier FG, Steinbach JH. The modulation of neurotransmitter synthesis by steroid hormones and insulin. Brain Res 1980;190:67-79.
87. Scott DL, Symmons DP, Coulton BL, Popert AJ. Long-term outcome of treating rheumatoid arthritis: Results after 20 years. Lancet 1987;1:1108-11.
88. Spath-Schwalbe E, Hansen K, Schmidt F, Schrezenmeier H, Marshall L, Burger K, Fehm HL, Born J. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol Metab 1998;83:1573-9.
89. Spector TD, Perry LA, Tubb G, Silman AJ, Huskisson EC. Low flee testosterone levels in rheumatoid arthritis. Ann Rheum Dis 1988;47:65-8.
90. Stein A, Yassouridis A, Szopko C, Helmke K, Stein C. Intraarticular morphine versus dexamethasone in chronic arthritis. Pain 1999;83:525-32.
91. Straub RH. Tables of Molecular and Functional Neuroendocrine Immune Interactions. Eching: Biozol 2000.
92. Straub RH, Günzler C, Miller LE, Cutolo M, Schölmerich J, Schill S. Anti-inflammatory cooperativity of comcosteroids and norepinephrine in rheumatoid arthritis synovial tissue in vivo and in vitro. FASEB J 2002;16:993-1000.
93. Straub RH, Konecna L, Hrach S, Rothe G, Kreutz M, Schölmerich J, Falk W, Lang B. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: Possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 1998;83:2012-7.
94. Straub RH, Paimela L, Pelromaa R, Schölmerich J, Leirisalo-Repo M. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthritis Rheum 2002;46:654-62.
95. Straub RH, Vogl D, Gross V, Lang B, Schölmerich J, Andus T. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease. Am J Gastroenterol 1998;93:2197-202.
96. Straub RH, Westermann J, Schölmerich J, Falk W. Dialogue between the CNS and the immune system in lymphoid organs. Immunol Today 1998;19:409-13.
97. Takeda T, Mizugaki Y, Matsubara L, Imai S, Koike T, Takada K. Lytic Epstein-Barr virus infection in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 2000;43:1218-25.
98. Templ E, Koeller M, Riedl M, Wagner O, Graninger W, Luger A. Anterior pituitary function in patients with newly diagnosed rheumatoid arthritis. Br J Rheumatol 1996;35:350-6.
99. Trang LE, Lovgren O, Roch-Norlund AE, Horn RS, Walaas O. Cyclic nucleotides in joint fluid in rheumatoid arthritis and in Reiter's syndrome. Scand J Rheumatol 1979;8:91-6.
100. Van de Putte LB, Meijer CJ, Lafeber GJ, Kleinjan R, Cats A. Lymphocytes in rheumatoid and nonrheumatoid synovial fluids. Nonspecificity of high T-cell and low B-cell percentages. Ann Rheum Dis 1975;35:451-5.
101. Van den Brink HR, Blankenstein MA, Koppeschaar HP, Bijlsma JW. Influence of disease activity on steroid hormone levels in peripheral blood of patients with rheumatoid arthritis. Clin Exp Rheumatol 1993;11:649-52.
102. van der Poll T, Barber AE, Coyle SM, Lowry SF. Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia - A clinical research center study. J Clin Endocrinol Metab 1996;81:3604-6.
103. Van Vollenhoven RF, Engleman EG, McGuire JL. Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial. Arthritis Rheum 1995;38:1826-31.
104. Weissmann G, Korchak H. Rheumatoid arthritis. The role of neutrophil activation. Inflammation 1984;8:Suppl:S3-14.
105. Wollenhaupt J, Zeidler H. Behandlung der rheumatoiden arthritis mit basistherapeutika-kombinationen. Dtsch Ärztebl 2001;98:A1196-200.
106. Zietz B, Reber T, Oertel M, Glück T, Schölmerich J, Straub RH. Altered function of the hypothalamic stress axes in patients with moderately active systemic lupus erythematosus. II. Dissociation between androstenedione, cortisol, or dehydroepiandrosterone and interleukin 6 or tumor necrosis factor. J Rheumatol 2000;27:911-8.